Clinical trial
Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients…
NCT00312806 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00312806 |
|---|---|
| Title | Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) |
| Official title | Real Life: Treatment Response in Patients With Symptoms Due to Gastroesophageal Reflux Disease Either With or Without Esophagitis Treated With Pantoprazole Sodium 40 mg o.d. Over 8 Weeks |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease (GERD) |
| Intervention type | Drug |
| Interventions | Pantoprazole |
| Enrollment | 2,000 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Apr 11, 2006 |
| Last update posted | May 7, 2012 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, France, Germany, Hong Kong, India, Italy, Malaysia and 10 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: